Live · Open opportunity
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
National Institutes of Health
- Issuer
- National Institutes of Health
- Type
- Federal funding opportunity
- Jurisdiction
- federal
- Posted
- August 31, 2026
- Closes
- June 16, 2028
Detail
This notice of funding opportunity (NOFO) uses a R61/R33 Phased Innovation Award activity code to support clinical research applications that are exploratory and developmental in nature and focus on understanding the neurobiological mechanisms underlying substance use disorders (SUD), including fundamental circuitry and behavior relevant to substance use. For projects not requiring a phased research approach, applicants are encouraged to apply under a different funding activity code (e.g., PA-25-305 "Research Project Grant (Parent R01 Clinical Trial Required)" or its subsequent reissue).
View the full solicitation and how to apply ↗
Free account
Create a free account
Track New York opportunities and save searches across the Market. Free. No card required.
Want a strategy to win work like this? Build your Market Network Strategic Plan →
